A novel function of R-spondin1 in regulating estrogen receptor expression independent of Wnt/β-catenin signaling

  1. Ajun Geng
  2. Ting Wu
  3. Cheguo Cai
  4. Wenqian Song
  5. Jiqiu Wang
  6. Qing Cissy Yu  Is a corresponding author
  7. Yi Arial Zeng  Is a corresponding author
  1. State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology, University of Chinese Academy of Sciences, China
  2. Medical Research Institute, Wuhan University, China
  3. Department of Endocrinology and Metabolism, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (SJTUSM), China
  4. School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Chinese Academy of Sciences, China
8 figures, 1 table and 1 additional file

Figures

Figure 1 with 2 supplements
Rspo1 enhances Esr1 transcription and ERα signaling activities.

(a) RNA-seq of 3D cultured luminal cells in the presence of RSPO1 (0.5 μg/ml) or vehicle. Increased expression of ERα target genes (Pgr, Greb1) and Esr1 were enlisted in heatmap of differentially …

Figure 1—figure supplement 1
Rspo1 promotes ERα signaling activities.

(a) Sorted Lin-, CD24+, CD29lo luminal cells were cultured in Matrigel as illustrated. (b) qPCR validation indicating increased Esr1 expression and upregulation of ERα target genes in response to …

Figure 1—figure supplement 2
RSPO1 induces Esr1 expression in a dose-dependent manner in Eph4 cell line.

(a) RSPO1 treatment induced the expression of Esr1 in a dose-dependent manner. (b,c) ERα signaling target genes Pgr (b) and Greb1 (c) were upregulated dose-dependently in the presence of RSPO1. Data …

Figure 2 with 1 supplement
Rspo1 inducing Esr1 expression is dependent on Lgr4.

(a) qPCR analysis of Lgrs in FACS-isolated basal and luminal cells. Lgr4, Lgr5 and Lgr6 are all expressed in basal cells, while only Lgr4 is distinctively expressed in luminal cells with even …

Figure 2—figure supplement 1
Validation of LGR4 shRNAs knockdown efficiency.

(a) qPCR analysis of LGR4 expression in T47D cells indicating successful knockdown by shRNA.

Esr1 expression induced by Rspo1 is independent of Wnt/β-catenin signaling.

(a–b) qPCR analysis of cultured luminal cells indicating that Wnt4 alone or in combination with RSPO1 can activate Wnt target Axin2 expression (a). While RSPO1 alone promoted Esr1 expression, Wnt4 …

Figure 4 with 2 supplements
Loss of Rspo1 in mammary luminal cells results in reduced side branching and decreased ERα expression.

(a) Schematic illustration of Rspo1flox knock-in allele generation (see also Figure 4—figure supplement 1). (b) Krt8-CreER;Rspo1fl/fl inducible model specifically knockdown Rspo1 in luminal cells. (c…

Figure 4—figure supplement 1
Generation of Rspo1flox mouse model.

(a) Targeting strategy to generate the Rspo1flox knock-in (KI) mouse. Design of genotyping primers are as indicated. Exon2 of the Rspo1 gene was replaced by inserting cassette. (b) Pups born from …

Figure 4—figure supplement 2
Loss of Lgr4 reduces Esr1 expression and ERα signaling activities.

(a) Lgr4-/- mammary glands display reduced side branches. (b) Quantification of side branches was performed in designated area. More than six views were used for quantification. (c) Immunostaining …

Figure 5 with 1 supplement
Loss of Wnt4 increases Esr1 expression in luminal cells.

(a) Schematic illustration of Wnt4flox knock-in allele generation (see also Figure 5—figure supplement 1). (b) Krt8-CreER;Wnt4flox inducible model specifically knockdown Wnt4 in luminal cells. (c–d) …

Figure 5—figure supplement 1
Generation of Wnt4flox mouse model.

(a) Targeting strategy to generate the Wnt4flox knock-in (KI) mouse. Design of genotyping primers are as indicated. Exon2 of the Wnt4 gene was replaced by inserting cassette. (b) Pups born form …

Figure 6 with 1 supplement
Rspo1 inducing Esr1 expression relies on cAMP-PKA pathway.

(a) HEK293T cells transfected with ESR1-luciferase reporter were cultured in the presence of RSPO1, and in combination with pharmaceutical compounds from a GPCR inhibitor library (Selleck). …

Figure 6—source data 1

ESR1-luciferase activities induced by RSPO1 in combination with a GPCR inhibitor library.

https://cdn.elifesciences.org/articles/56434/elife-56434-fig6-data1-v1.xls
Figure 6—figure supplement 1
ESR1-luciferase activities induced by RSPO1 in combination with a GPCR inhibitor library HEK293 cells with transiently expressing ESR1-luciferase reporter were cultured in the presence of RSPO1, and screened for the molecules that could suppress the luciferase activities using a GPCR inhibitor library (Selleck, L2200).

Luciferase activities were measured.

Author response image 1
Author response image 2

Tables

Key resources table
Reagent type
(species) or resource
DesignationSource or referenceIdentifiersAdditional
information
Genetic reagent (M. musculus)Krt8-CreERT2PMID:22350718RRID:MGI:5314229Dr. Li Xin (Department of Molecular and Cellular Biology, Baylor College of Medicine, United States)
Genetic reagent (M. musculus)Rspo1flox/+This paperGenerated in our laboratory Detail refer to Figure 4 and Figure 4—figure supplement 1
Genetic reagent (M. musculus)Wnt4flox/+This paperGenerated in our laboratory Detail refer to Figure 5 and Figure 5—figure supplement 1
Genetic reagent (M. musculus)Lgr4LacZ/+PMID:15192078RRID:MGI:3052121Drs. Minyao Liu and Dali Li
Cell line (M. musculus)Eph4PMID:25260709Mouse mammary epithelial cell line
Cell line (H. sapiens)HEK293T (293T)http://www.cellbank.org.cnCat. #: SCSP-502
Cell line (H. sapiens)T47DDr. Gaoxiang Ge's laboratoryHuman breast cancer cell line
Dr. Gaoxiang Ge (Institute of Biochemistry and Cell Biology)
AntibodyRabbit anti Gapdh GAPDH Polyclonal AntibodyProteintechCat. #: 10494–1-AP
RRID:AB_2263076
WB (1:3000)
AntibodyMouse anti β-Actin Monoclonal AntibodySigmaCat. #: A2228
RRID:AB_476697
WB (1:2000)
AntibodyRabbit anti ERα Polyclonal AntibodyMilliporeCat. #: 06–935
RRID:AB_310305
WB (1:1000), IHC (1:200)
AntibodyRat anti Krt8 Monoclonal AntibodyDSHBCat. #: TROMA-1IHC (1:500)
AntibodyRat Anti-Mouse CD31 Monoclonal Antibody, Biotin ConjugatedBD PharMingenCat. #: 553371
RRID:AB_394817
Flow cytometry (1:200)
AntibodyRat Anti-Mouse CD45 Monoclonal Antibody, Biotin ConjugatedBD PharMingenCat. #: 553078
RRID:AB_394608
Flow cytometry (1:200)
AntibodyRat Anti-Mouse TER-119 Monoclonal Antibody, Biotin ConjugatedBD PharMingenCat. #: 553672Flow cytometry (1:200)
AntibodyRat Anti-Mouse CD31 Monoclonal Antibody, FITC ConjugatedBD PharMingenCat. #: 553372
RRID:AB_394818
Flow cytometry (1:200)
AntibodyRat Anti-Mouse CD45 Monoclonal Antibody, FITC ConjugatedBD PharMingenCat. #: 553080
RRID:AB_394610
Flow cytometry (1:200)
AntibodyRat Anti-Mouse TER119 Monoclonal Antibody, FITC ConjugatedBD PharMingenCat. #: 557915Flow cytometry (1:200)
AntibodyPE/Cy7 Rat Anti-Mouse CD24 Monoclonal AntibodyBiolegendCat. #: 101–822
RRID:AB_756048
Flow cytometry (1:200)
AntibodyAPC Armenian Hamster Anti-Mouse/Rat CD29 Monoclonal AntibodyBiolegendCat. #: 102216
RRID:AB_492833
Flow cytometry (1:200)
AntibodyRat Anti-Ly-6A/E (Sca-1) Monoclonal Antibody, PEeBioscienceCat. #: 12-5981-82
RRID:AB_466086
Flow cytometry (1:200)
AntibodyStreptavidin eFluor 450 ConjugateeBioscienceCat. #: 48-4317-82
RRID:AB_10359737
Flow cytometry (1:200)
Peptide, recombinant proteinEpithelial growth factor (EGF)CorningCat. #: 35400150 ng/mL
Peptide, recombinant proteinFzCRDPMID:25260709Inhibition of the Frizzled receptor using its soluble CRD domain. Purified in our laboratory (1:200)
Peptide, recombinant proteinWnt3APMID:20569694Purified in our laboratory 200 ng/ml
Recombinant DNA reagentplko.1 backboneAddgeneRRID:Addgene_30323
Recombinant DNA reagentpGL4.17 basic vectorPromega, Madison, WI, U.S.A.Cat. #: E6721
Recombinant DNA reagentpRL-TK RenillaPromega, Madison, WI, U.S.A.Cat. #: E2241
Recombinant DNA reagentpcDNA3.1-RSPO1 overexpression (RSPO1-OE) plasmidThis paperConstructed in our laboratoryDetail refer to Materials and methods
Chemical compound, drugtamoxifen (TAM)Sigma-AldrichCat. #: T56482 mg/20 g
Chemical compound, drugHEPESSigmaCat. #: H4034-500G25 mM
Chemical compound, drugCollagenase IIIWorthingtonCat. #: LS004183300 U/ml
Chemical compound, drugred blood cell lysing bufferSigmaCat. #: R7757
Chemical compound, drugDNase ISigmaCat. #: D42630.1 mg/mL
Chemical compound, drugCarmineSigmaCat. #: C10222 mg/ml
Chemical compound, drugHistoclearNational DiagnosticsCat. #: HS-200
Chemical compound, drugMatrigelBD BioscienceCat. #: 354230
Chemical compound, drugInsulin-Transferrin-Selenium (ITS)GibcoCat. #: 41400045Cell culture (1:100)
Chemical compound, drugE2SigmaCat. #: E88751 μM
Chemical compound, drugIWP2SelleckCat. #: s70852.5 μM
Chemical compound, drugCHIRSelleckCat. #: S12633 μM
Chemical compound, drugXAV-939SelleckCat. #: S118010 μM
Chemical compound, drugProtein A AgaroseSanta CruzCat. #: sc-2003
Chemical compound, drugDAPILife TechnologiesCat. #: P36931
Chemical compound, drugGPCR compound librarySelleckchem L2200Chemical Biology Core Facility, Institute of Biochemistry and Cell Biology, SIBS, CAS
Commercial assay or kitIn situ hybridization RNAscope kitAdvanced Cell DiagnosticsFollowing the manufacturer’s instructions
Commercial assay or kitDual-Luciferase Reporter Assay SystemPromegaCat. #: E1910Following the manufacturer’s instructions
Commercial assay or kitcAMP-Glo assay kitPromegaCat. #: V1501Following the manufacturer’s instructions
Commercial assay or kitSuperScript III kitInvitrogenCat. #: RR036AFollowing the manufacturer’s instructions
Software, algorithmGraphPad PrismGraphPad Prism (https://graphpad.com)
Software, algorithmImageJImageJ (http://imagej.nih.gov/ij/)

Additional files

Download links